Showing results (3461-3470 of 4,889) with videos related to

Sort By:
Pageof 489
Science Translational Medicine|September 4, 2024
PTPRT loss enhances anti-PD-1 therapy efficacy by regulation of STING pathway in non-small cell lung cancerZhuo Chen, Wenxiang Ji, Wenxin Feng, et al.
Science Translational Medicine|June 19, 2024
A subpopulation of tissue remodeling monocytes stimulates revascularization of the ischemic limbAshish S Patel, Francesca E Ludwinski, Alexander Kerr, et al.
Science Translational Medicine|June 19, 2024
Topical JAK inhibition ameliorates EGFR inhibitor-induced rash in rodents and humansQing You, Leying Chen, Shuaihu Li, et al.
Science Translational Medicine|June 26, 2024
Proteomic analysis of Alzheimer's disease cerebrospinal fluid reveals alterations associated with APOE ε4 and atomoxetine treatmentEric B Dammer, Anantharaman Shantaraman, Lingyan Ping, et al.
Science Translational Medicine|May 1, 2024
Electronic health record signatures identify undiagnosed patients with common variable immunodeficiency diseaseRuth Johnson, Alexis V Stephens, Rachel Mester, et al.
Science Translational Medicine|May 1, 2024
Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndromeGiulia Consiglieri, Francesca Tucci, Maurizio De Pellegrin, et al.
Science Translational Medicine|June 12, 2024
Prolonged xenokidney graft survival in sensitized NHP recipients by expression of multiple human transgenes in a triple knockout pigMiriam Manook, Danae Olaso, Imran Anwar, et al.
Science Translational Medicine|June 12, 2024
Heterotypic immunity from prior SARS-CoV-2 infection but not COVID-19 vaccination associates with lower endemic coronavirus incidenceDavid J Bean, Janet Monroe, Yan Mei Liang, et al.
Science Translational Medicine|June 12, 2024
Nutrient-sensitizing drug repurposing screen identifies lomerizine as a mitochondrial metabolism inhibitor of chronic myeloid leukemiaAhmed Khalaf, Lucie de Beauchamp, Eric Kalkman, et al.
Science Translational Medicine|May 22, 2024
The oral nucleoside prodrug GS-5245 is efficacious against SARS-CoV-2 and other endemic, epidemic, and enzootic coronavirusesDavid R Martinez, Fernando R Moreira, Nicholas J Catanzaro, et al.
Pageof 489